Anavex Life Sciences Statistics

Total Valuation

AVXL has a market cap or net worth of $793.65 million. The enterprise value is $671.17 million.

Market Cap	793.65M
Enterprise Value	671.17M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

AVXL has 85.06 million shares outstanding. The number of shares has increased by 4.13% in one year.

Current Share Class	85.06M
Shares Outstanding	85.06M
Shares Change (YoY)	+4.13%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	3.30%
Owned by Institutions (%)	35.19%
Float	82.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.13
P/TBV Ratio	7.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.45

Current Ratio	9.45
Quick Ratio	9.39
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -37.72% and return on invested capital (ROIC) is -26.87%.

Return on Equity (ROE)	-37.72%
Return on Assets (ROA)	-24.34%
Return on Invested Capital (ROIC)	-26.87%
Return on Capital Employed (ROCE)	-47.77%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +153.53% in the last 52 weeks. The beta is 0.80, so AVXL's price volatility has been lower than the market average.

Beta (5Y)	0.80
52-Week Price Change	+153.53%
50-Day Moving Average	8.76
200-Day Moving Average	7.75
Relative Strength Index (RSI)	55.97
Average Volume (20 Days)	1,161,497

Short Selling Information

The latest short interest is 24.59 million, so 28.91% of the outstanding shares have been sold short.

Short Interest	24.59M
Short Previous Month	24.04M
Short % of Shares Out	28.91%
Short % of Float	29.89%
Short Ratio (days to cover)	21.81

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.98M
Pretax Income	-41.47M
Net Income	-46.49M
EBITDA	n/a
EBIT	-52.98M
Earnings Per Share (EPS)	-$0.55

Full Income Statement

Balance Sheet

The company has $120.78 million in cash and n/a in debt, giving a net cash position of $120.78 million or $1.42 per share.

Cash & Cash Equivalents	120.78M
Total Debt	n/a
Net Cash	120.78M
Net Cash Per Share	$1.42
Equity (Book Value)	110.92M
Book Value Per Share	1.31
Working Capital	110.92M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-35.61M
Capital Expenditures	n/a
Free Cash Flow	-35.61M
FCF Per Share	-$0.42

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.13%
Shareholder Yield	-4.13%
Earnings Yield	-5.87%
FCF Yield	-4.50%

Analyst Forecast

The average price target for AVXL is $44.00, which is 371.60% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$44.00
Price Target Difference	371.60%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 7, 2015. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Oct 7, 2015
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1